510(k) Report

FDA applicant

Phadia AB

Uppsala, SE34 decisions2007–20265 recalls

FDA records 34 decisions for Phadia AB (Uppsala, SE) from 2007 to 2026: 34 510(k) clearances. Most are in product codes DHB (System, Test, Radioallergosorbent (Rast)…) and DGC (Ige, Antigen, Antiserum, Control). Its devices cite 53 predicates, 5 of them its own earlier devices. 5 recalls are linked to its devices.

FDA’s records also spell it “Phadia GmbH”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, immunology panel, where it files most

How often FDA has decided Phadia AB’s devices, and how often a recall has named them.

FDA decisions per year

2in 2022

2007: 12009: 22010: 12011: 12013: 32014: 22015: 12016: 42017: 12018: 82019: 32020: 12021: 32022: 22026 (partial year): 1
2007high 8 (2018) · low 0 (2008)2026

2026 so far, outlined.

Recalls per year

1in 2023

2014: 12017: 22019: 12023: 1
2007high 2 (2017) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Phadia AB by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Phadia AB’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Phadia”

FDA records each applicant name separately; these may or may not be the same firm.